Promise of faster, more accessible schizophrenia diagnosis, study shows

May 30, 2018, Rutgers University
Promise of faster, more accessible schizophrenia diagnosis, Rutgers study shows
Docia Demmin (left) and Steven Silverstein demonstrate how the hand-held device RETeval may prove to be a more accessible way to diagnose schizophrenia, predict relapse and symptom severity, and assess treatment effectiveness. Credit: Nick Romanenko / Rutgers University

A portable device common in optometrists' offices may hold the key to faster diagnosis of schizophrenia, predicting relapse and symptom severity and assessing treatment effectiveness, a Rutgers University study finds.

In the study, published in the May 2018 issue of the Journal of Abnormal Psychology, researchers used RETeval, a hand-held developed to record from the retina, to replicate and extend prior studies showing that people with had in the retina. This was the first time a was used for these tests. The results show the device accurately indicated reduced electrical activity in the retina in multiple cell layers in the participants who had schizophrenia, including in cell types that had not been studied before in this disorder.

"Schizophrenia is a devastating disorder, probably the most disabling disorder long term. Although we know quite a bit about it, it's still not that well understood," said Steven Silverstein, professor of psychiatry at Rutgers Robert Wood Johnson Medical School and director of research at Rutgers University Behavioral Health Care (UBHC), who designed the study. "Our study should help generate further research into developing a that clinicians—like psychologists, psychiatrists or nurses—can use in their offices to diagnose, treat and monitor the condition of people with schizophrenia."

Looking at biomarkers in the eye as a way to understand psychiatric disorders is a new field of study.

"Since the retina is part of the nervous system, what is happening in the retina is likely reflective of what is occurring in the brain," Silverstein said. "For example, we know that certain changes in the retina, like thinning tissue [due to cell loss] or weakening electrical activity, occur alongside loss of brain tissue and reduced brain activity in patients with neurological like multiple sclerosis and Parkinson's disease. We and other researchers are now investigating whether retinal changes are related to brain structure and function changes in schizophrenia."

In the just-published study, the researchers evaluated 50 participants: 25 with schizophrenia and 25 with no diagnosed psychiatric disorder. In the test, the participants closed one eye and placed the other against the RETeval device, which flashed 10 to 20 white or colored lights of various intensity against a white or colored background. A tiny skin electrode was placed on the skin under the eye to record the 's electrical activity. The participants were tested in normal light and after sitting in the dark for 10 minutes to assess activity in different types of retinal cells. Most individual tests were completed within two minutes.

"Since many of our participants were experiencing severe psychiatric symptoms, such as hallucinations and delusions, we wanted to use a test that was as noninvasive and quick as possible," Silverstein said.

"While the portable device clearly distinguished people with schizophrenia from those without a psychiatric diagnosis, it's too soon to call this a diagnostic tool," said lead author Docia Demmin, a graduate assistant in UBHC's Division of Schizophrenia Research and a doctoral student in Rutgers Department of Psychology. "However, since every prior study has found that people with schizophrenia exhibit reduced retinal wave forms and slowed retinal responses, our research shows that we closing in on an accurate test that is faster, less invasive, inexpensive and more accessible to patients."

Explore further: Tracking vision fluctuations may help doctors adjust schizophrenia treatment for each patient

More information: Docia L. Demmin et al, Electroretinographic anomalies in schizophrenia., Journal of Abnormal Psychology (2018). DOI: 10.1037/abn0000347

Related Stories

Tracking vision fluctuations may help doctors adjust schizophrenia treatment for each patient

September 9, 2015
Tracking changes in the eye's retina may help doctors provide more effective treatment for people with schizophrenia, according to researchers at Rutgers University and Mount Sinai's New York Eye and Ear Infirmary.

Retinal changes may serve as measures of brain pathology in schizophrenia

August 17, 2015
Schizophrenia is associated with structural and functional alterations of the visual system, including specific structural changes in the eye. Tracking such changes may provide new measures of risk for, and progression of ...

Substance use disorders linked to conversion to schizophrenia

April 26, 2018
(HealthDay)—Substance use disorders are associated with conversion from schizotypal disorder to schizophrenia, according to a study published online April 25 in JAMA Psychiatry.

Brain connections in schizophrenia

March 9, 2018
Executive cognitive functions—abilities that include working memory and underlie mental control and self-regulation—are impaired in schizophrenia. Current pharmacological and behavioral interventions have only modest ...

Shared genetics in schizophrenia and bipolar disorder

October 2, 2017
A genetic variant associated with multiple psychiatric disorders drives changes in a brain network that may increase an individual's risk of developing bipolar disorder and schizophrenia, finds a study published in Journal ...

Study sheds light on genetic overlap between major psychiatric disorders

February 8, 2018
Most medical disorders have well-defined physical characteristics seen in tissues, organs and bodily fluids. Psychiatric disorders, in contrast, are not defined by such pathology, but rather by behavior.

Recommended for you

People are more honest when using a foreign tongue, research finds

August 17, 2018
New UChicago-led research suggests that someone who speaks in a foreign language is probably more credible than the average native speaker.

FDA approves brain stimulation device for OCD

August 17, 2018
(HealthDay)—A brain stimulation device to treat obsessive-compulsive disorder (OCD) has received approval for marketing Friday by the U.S. Food and Drug Administration.

Research eyes role of stress in mental illnesses

August 17, 2018
We all face stress in our lives. Even researchers seeking to understand why some people shrug it off while others face battles against disorders like depression or PTSD.

16 going on 66: Will you be the same person 50 years from now?

August 17, 2018
How much do you change between high school and retirement? The answer depends on whether you're comparing yourself to others or to your younger self.

Men and women show surprising differences in seeing motion

August 16, 2018
Researchers reporting in the journal Current Biology on August 16 have found an unexpected difference between men and women. On average, their studies show, men pick up on visual motion significantly faster than women do.

It's okay when you're not okay: Study re-evaluates resilience in adults

August 16, 2018
Adversity is part of life: Loved ones die. Soldiers deploy to war. Patients receive terminal diagnoses.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.